|
|
click this icon for latest updates
Victor Dasgupta January 13, 2023 1:19 AM IST
Covovax is manufactured through technology transfer from Novavax. It has been approved by the European Medicines Agency for conditional marketing authorization.
India.com News Desk June 28, 2022 10:39 PM IST
Precaution dose of Covid-19 vaccines for all aged above 18 years began at private vaccination centres from April 10.
India.com News Desk June 24, 2022 11:14 PM IST
Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9.
PTI May 3, 2022 1:35 AM IST
In his letter, Singh had stated that the Pune-based firm wanted to provide Covovax to private hospitals at a per-dose rate of Rs 900 plus Goods and Services Tax (GST).
India.com News Desk April 29, 2022 5:32 PM IST
The Central Drugs Standard Control Organisation's Subject Expert Committee had approved the Serum Institute of India's Covovax for restricted use in emergency situations in adults on December 28. On March 9, it recommended granting the Emergency Use Authorisation for Covovax for the 12-17 age group.
India.com News Desk April 8, 2022 5:51 PM IST
Giving details, Adar Poonawala said the Serum Institute will offer large discounts to hospitals and distributors who like to offer booster doses.
PTI March 23, 2022 9:33 PM IST
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28 last year and for inoculating the beneficiaries in the 12-17 years age group, subject to certain conditions, on March 9.
India.com News Desk March 23, 2022 6:48 AM IST
Covovax is the fourth vaccine to receive EUA from the DCGI for use among adolescents 12 and older.
India.com News Desk March 9, 2022 5:48 PM IST
The approval from Drugs Controller General Of India's (DCGI) comes after the Subject Expert Committee on COVID-19 of the CDSCO last week recommended granting emergency use authorisation (EUA) to Covovax for those aged 12 to 17.
India.com News Desk March 4, 2022 10:10 PM IST
The Drugs Controller General of India (DCGI) had approved Covovax for restricted emergency use in adults on December 28.
India.com News Desk February 27, 2022 6:14 PM IST
The Drugs Controller General Of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28. The vaccine is yet to be included in the country's inoculation programme.
India.com News Desk February 21, 2022 7:29 PM IST
Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing authorisation. It has been granted emergency use listing by the World Health Organisation on December 17, 2021.
India.com Lifestyle Staff December 29, 2021 11:58 AM IST
India has agreed to the use of two vaccines corbevax and covavax along with molnupiravir, an antiviral oral pill for the treatment of covid-19 patients. Read on to know more about the efficiency.
India.com News Desk December 29, 2021 7:53 AM IST
The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for Covovax, biotechnology company Novavax said in a statement.
India.com News Desk December 28, 2021 7:23 AM IST
The announcement comes a day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation (EUA) to the COVID-19 vaccines Covovax and Corbevax with certain conditions.
India.com News Desk December 21, 2021 10:57 PM IST
WHO said Nuvaxovid was around 90 per cent effective at reducing symptomatic cases of COVID-19 in two major clinical studies.
India.com News Desk December 17, 2021 9:05 PM IST
WHO on Friday granted Emergency Use Listing to Covovax, the coronavirus vaccine developed by the Serum Institute of India in partnership with the US-based Novavax.
India.com News Desk December 14, 2021 3:51 PM IST
Serum Institute of India (SII) is planning to launch its COVID-19 vaccine for children, Covavax, in six months, CEO Adar Poonawalla said on Tuesday.
India.com News Desk November 28, 2021 2:18 PM IST
Serum Institute is manufacturing doses of the Novavax COVID-19 vaccine with the name 'Covovax' in India.
India.com News Desk October 29, 2021 9:26 PM IST
The SII has also submitted interim phase 2/3 clinical study report on Indian adults, the interim report of Novavax UK and USA-Mexico phase-3 clinical study and response to the queries raised by the DCGI office, along with its application.
India.com News Desk October 21, 2021 5:57 PM IST
Earlier, Adar Poonawalla had said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
India.com News Desk October 1, 2021 8:48 AM IST
Nine centres have been identified across India for this phase, including Bharati Vidyapeeth Medical College Hospital.
India.com News Desk August 6, 2021 9:18 PM IST
On production capacity of Covishield, the vaccine being manufactured and supplied by SII under a licensing agreement with Oxford and AstraZeneca, he said the present capacity is 130 million doses per month and the company is always trying to increase it further.
India.com News Desk July 1, 2021 8:06 AM IST
The SII had sought permission to conduct the phase 2/3 trial of the Indian version of US-based Novavax Inc-developed vaccine named Covovax on children aged two to 17 years, sources said.
Follow Us 